Dose-Optimized Nilotinib (NIL) in Patients (Pts) with Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase (CML-CP): Final Results from ENESTxtnd Study

Timothy P. Hughes; Marco Aurelio Salvino; Ong Tee Chuan; Alaa Elhaddad; Kudrat Abdulkadyrov; Jake Shortt; Hang Quach; Carolina Pavlovsky; Vernon J. Louw; Lee-Yung Shih; Anna G. Turkina; Luis Meillon; Yu Jin; Sadhvi Khanna; Darshan Dalal; Jeffrey H. Lipton

Dose-Optimized Nilotinib (NIL) in Patients (Pts) with Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase (CML-CP): Final Results from ENESTxtnd Study

Timothy P. Hughes
, Marco Aurelio Salvino
, Ong Tee Chuan
, Alaa Elhaddad
, Kudrat Abdulkadyrov
, Jake Shortt
, Hang Quach
, Carolina Pavlovsky
, Vernon J. Louw
, Lee-Yung Shih
, Anna G. Turkina
, Luis Meillon
, Yu Jin
, Sadhvi Khanna
, Darshan Dalal
, Jeffrey H. Lipton

醫學系

研究成果: 期刊稿件 › 文章 › 同行評審

原文	美式英語
期刊	Blood
卷	126
發行號	23
出版狀態	已出版 - 2015

UN SDG

此研究成果有助於以下永續發展目標

SDG3 健康與福祉

引用此

Hughes, T. P., Salvino, M. A., Chuan, O. T., Elhaddad, A., Abdulkadyrov, K., Shortt, J., Quach, H., Pavlovsky, C., Louw, V. J., Shih, L.-Y., Turkina, A. G., Meillon, L., Jin, Y., Khanna, S., Dalal, D., & Lipton, J. H. (2015). Dose-Optimized Nilotinib (NIL) in Patients (Pts) with Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase (CML-CP): Final Results from ENESTxtnd Study. Blood, 126(23).

@article{212e6af2c25f48ef9a5d7e613146a5b1,

title = "Dose-Optimized Nilotinib (NIL) in Patients (Pts) with Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase (CML-CP): Final Results from ENESTxtnd Study",

author = "Hughes, \{Timothy P.\} and Salvino, \{Marco Aurelio\} and Chuan, \{Ong Tee\} and Alaa Elhaddad and Kudrat Abdulkadyrov and Jake Shortt and Hang Quach and Carolina Pavlovsky and Louw, \{Vernon J.\} and Lee-Yung Shih and Turkina, \{Anna G.\} and Luis Meillon and Yu Jin and Sadhvi Khanna and Darshan Dalal and Lipton, \{Jeffrey H.\}",

year = "2015",

language = "American English",

volume = "126",

journal = "Blood",

issn = "0006-4971",

publisher = "Elsevier B.V.",

number = "23",

}

Hughes, TP, Salvino, MA, Chuan, OT, Elhaddad, A, Abdulkadyrov, K, Shortt, J, Quach, H, Pavlovsky, C, Louw, VJ, Shih, L-Y, Turkina, AG, Meillon, L, Jin, Y, Khanna, S, Dalal, D & Lipton, JH 2015, 'Dose-Optimized Nilotinib (NIL) in Patients (Pts) with Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase (CML-CP): Final Results from ENESTxtnd Study', Blood, 卷 126, 編號 23.

TY - JOUR

T1 - Dose-Optimized Nilotinib (NIL) in Patients (Pts) with Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase (CML-CP): Final Results from ENESTxtnd Study

AU - Hughes, Timothy P.

AU - Salvino, Marco Aurelio

AU - Chuan, Ong Tee

AU - Elhaddad, Alaa

AU - Abdulkadyrov, Kudrat

AU - Shortt, Jake

AU - Quach, Hang

AU - Pavlovsky, Carolina

AU - Louw, Vernon J.

AU - Shih, Lee-Yung

AU - Turkina, Anna G.

AU - Meillon, Luis

AU - Jin, Yu

AU - Khanna, Sadhvi

AU - Dalal, Darshan

AU - Lipton, Jeffrey H.

PY - 2015

Y1 - 2015

M3 - Journal Article

SN - 0006-4971

VL - 126

JO - Blood

JF - Blood

IS - 23

ER -